Cellular immunology · 2010
Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yassin Lina M, Rojas Mauricio, Ramírez Luis A, García Luis F, Vásquez Gloria
Аннотация
Decreased apoptotic cells (ACs) removal has been described as relevant in systemic lupus erythematosus (SLE) pathogenesis. Binding/phagocytosis of ACs was decreased in SLE patients. Blocking experiments suggested a role for CD36 in ACs clearance in healthy controls, not observed in SLE patients. Binding/phagocytosis of ACs induced the production of IL-6, CXCL8 and CCL22 in patients and controls and IL-1β, TNF-α and CCL3 only in healthy controls. ACs clearance induced an increase in CD80 and a decrease in CD86 expression in healthy controls and atherosclerotic patients. However, SLE patients did not up-regulate CD80 expression. The number and expression of CD36 and CD163 in monocytes was not different between the groups. ACs removal induced a down-regulation of CD36 expression in adherent HLA-DR(+) cells in SLE patients but not healthy controls. The decreased binding/phagocytosis of ACs observed in SLE patients, induces a distinct immune response compared with healthy controls.
Предметные рубрики MeSH
AdultAgedAntibodies, MonoclonalAntigens, CDAntigens, Differentiation, MyelomonocyticApoptosisAtherosclerosisB7-1 AntigenB7-2 AntigenCD36 AntigensCD40 AntigensChemokine CCL2Chemokine CCL22Chemokine CCL3Culture Media, ConditionedFemaleHLA-DR AntigensHumansInterleukin-1betaInterleukin-6Interleukin-8Leukocytes, MononuclearLupus Erythematosus, SystemicMaleMiddle AgedMonocytesPhagocytosisReceptors, Cell SurfaceTumor Necrosis Factor-alphaYoung AdultCD163 Antigen